Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
+0.36 (0.58%)
Jun 13, 2024, 3:24 PM EDT - Market open

Insmed Revenue

Insmed had revenue of $315.49M in the twelve months ending March 31, 2024, with 22.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.50M with 15.77% year-over-year growth. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
10.00B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 201311.50M--
Dec 31, 20120--
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K-6.00K-4.38%
Dec 31, 2004137.00K-13.00K-8.67%
Dec 31, 2003150.00K-1.81M-92.33%
Dec 31, 20021.96M1.66M560.47%
Dec 31, 2001296.00K236.00K393.33%
Dec 31, 200060.00K--
Dec 31, 19990--
Dec 31, 19980--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Universal Health Services 14.66B
Elanco Animal Health 4.37B
Catalent 4.14B
Charles River Laboratories International 4.11B
AptarGroup 3.54B
Teleflex 3.00B
Bruker 3.00B
Qiagen 1.94B
Revenue Rankings